MedTrace Logo

Will Veterans Engage in Prevention After HRA-guided Shared Decision Making?

NCT01828567 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 417

Last updated 2018-09-10

Study results available
· View outcomes & findings →

Summary

The VA has committed to disseminate a web-based Healthy Living Assessment(HLA) tool and use it as the cornerstone of a personalized prevention plan to engage patients to improve their health behaviors that lead to high health risk. Health risk assessments done in isolation, however, do not generally lead to behavior change. Our study will test the effectiveness of a Shared Decision Making intervention designed to activate Veterans to enroll in effective prevention programs. The intervention will be conducted over the telephone, by a prevention coach, and will be linked to the patients' primary care team. The co-primary outcomes will be patient activation and patient enrollment in prevention programs; 10-year risk of major cardiac events will also be measured.

Conditions

Interventions

BEHAVIORAL

Shared decision making with a Prevention Coach

A series of two phone sessions with a prevention coach. The first to engage the veteran to choose a preferred prevention program and link them to Patient Aligned Care Team (PACT), and a follow-up call one month later to assess the progress of the prevention plan.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Eugene Z. Oddone, MD MHSc · Durham VA Medical Center, Durham, NC

  • Laura J. Damschroder, MPH · VA Ann Arbor Healthcare System, Ann Arbor, MI

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-01
Primary Completion
2016-12-30
Completion
2017-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01828567 on ClinicalTrials.gov